If You Invested in Syra Health (SYRA)

Syra Health Corp. (SYRA) is a healthcare technology and solutions company that focuses on improving health outcomes in key areas such as behavioral and mental health, population health, and the healthcare workforce. The company describes its offerings as prevention-focused, access-oriented, and designed to support affordable care for public and private healthcare organizations. Syra Health emphasizes healthcare prevention, expanding access to services, and delivering solutions that can positively affect entire populations.

According to multiple company disclosures, Syra Health serves both public sector and private sector healthcare organizations. Its customers include state, local, and county government agencies as well as major insurance providers and other healthcare organizations. The company highlights its work with Medicaid and Medicare-related markets and its role in supporting managed care and population health programs.

Business focus and solutions

Syra Health states that it specializes in population health solutions, behavioral and mental health programs, and healthcare workforce services. The Population Health business unit is a core focus, providing services such as data collection and analytics, large-scale program implementations, health education and training, and other solutions that support quality improvement and cost reduction goals for healthcare organizations. The company also operates a Healthcare Workforce business unit that includes clinical staffing and related services for healthcare providers and insurers.

The company reports that its healthcare analytics capabilities are used to generate proactive insights and data-driven intelligence for its customers. Syra Health also references HIPAA-compliant and fully accessible digital health solutions that are intended to enable measurable health outcomes in highly regulated healthcare environments. Through training and education offerings, the company aims to help healthcare organizations reduce costs and deliver consistent, high-quality care.

Technology and digital health capabilities

Syra Health describes itself as a healthcare technology company and highlights several technology-based offerings. The company notes that it has developed digital health solutions that are HIPAA-compliant and accessible, and that these tools are designed to support prevention, access, and affordability. In its public communications, Syra Health has referenced technology-based products that support mental health and population health, as well as a white-labeled chatbot called SyraBot that is deployed with a managed care organization. The company has also disclosed achieving ISO 27001:2022 certification, which it associates with its commitment to data protection and information security for its technology-based products.

In addition to analytics and digital tools, Syra Health reports using advanced data analytics to help major insurance providers enhance member health plans and support healthcare quality measures. The company has described work involving data visualizations and support for Healthcare Effectiveness Data and Information Set (HEDIS) call center activities, as well as analytics-driven outreach and program support for population health initiatives.

Customer segments and markets

Syra Health’s disclosures indicate that it serves a mix of public and private healthcare customers. On the public side, the company cites contracts and relationships with state agencies, including the Indiana Family and Social Services Administration (FSSA), and work with state and county government customers across the United States. Examples mentioned in company news include health worker training for home and community-based services for Medicaid beneficiaries and support for mental health-related programs under state divisions of mental health and addiction.

On the private sector side, Syra Health has reported contracts with major insurance providers. These arrangements include providing medical management nurses to support specific health plans, gathering and analyzing data to inform healthcare quality measures, and using analytics to optimize member plans. The company has also referenced contracts with national healthcare organizations to improve quality, enhance outcomes, and reduce costs through data analysis and member outreach.

Population health and behavioral health emphasis

Population health is a central theme in Syra Health’s business. The company repeatedly identifies its Population Health business unit as a key growth area and notes that it delivers services such as health education and training, data collection and analytics, and large-scale program implementations. These services are positioned to support government agencies and insurers in managing health outcomes across large member or patient populations.

Syra Health also highlights behavioral and mental health as a critical focus area. In its public communications, the company notes that it powers better health in mental health and behavioral health, and it has described initiatives such as specialized content within a digital platform aimed at supporting individuals living with Post-Traumatic Stress Disorder (PTSD). It has also referenced behavioral health-related contracts, including sessions for public health staff focused on secondary trauma support and staffing licensed mental health clinicians in school districts.

Healthcare workforce services

In addition to technology and analytics, Syra Health operates a Healthcare Workforce business unit. The company reports that this unit includes contracts to provide clinical staff such as medical management nurses for major insurance providers, as well as other healthcare workforce services. These workforce offerings are part of Syra Health’s broader approach to supporting healthcare organizations through both technology-enabled and staffing-related services.

Syra Health has also reported contracts for medical management nurses who work with healthcare providers and plan members to assess medical needs, interpret benefits, and connect members to appropriate care and support services. The company positions these workforce services as complementary to its analytics and population health capabilities.

Corporate structure, listing, and governance

Syra Health Corp. is incorporated in Delaware and has both Class A common stock and convertible Class B common stock, as described in its proxy statements and other SEC filings. The company has disclosed amendments to its Amended and Restated Certificate of Incorporation related to the conversion and transferability of Class B common stock, including changes approved by stockholders to remove automatic conversion upon death of a Class B stockholder and to allow transfers to certain related parties without conversion.

The company previously listed its common stock on the Nasdaq Capital Market under the symbol SYRA. In a public announcement, Syra Health stated that it decided to voluntarily delist from the Nasdaq Capital Market and indicated that it expected its common stock to trade on the OTC market. The company cited the desire to reduce costs associated with a Nasdaq listing and to focus on strengthening core fundamentals as reasons for the voluntary delisting. Syra Health has noted that it intends to continue providing information to shareholders and to facilitate quotation of its common stock on the OTC market, while acknowledging that there is no guarantee of continued trading.

Headquarters and organizational context

Syra Health identifies itself as a Carmel, Indiana-based company. The company has emphasized its connection to the Indiana community in its public communications and has highlighted its work on statewide programs in Indiana, including contracts related to Medicaid services and mental health initiatives. Its SEC filings list Carmel, Indiana as the location of its principal executive offices.

Leadership and governance developments

Syra Health has reported several leadership and governance developments through SEC filings and press releases. The Board of Directors initiated a national search for a new Chief Executive Officer as part of a succession plan and later appointed Gregory R. Alexander as Chief Executive Officer, with his employment agreement described in a Form 8-K filing. The company’s proxy materials outline the composition of the Board, the voting structure for Class A and Class B shares, and the matters submitted to stockholders at the annual meeting, including director elections and amendments to the certificate of incorporation.

Use of SEC filings and financial information

Investors reviewing Syra Health often look to its SEC filings, including quarterly and annual reports and current reports on Form 8-K, for details on its financial condition, business units, and risk factors. The company’s press releases and related Form 8-K filings provide additional context on revenue trends, segment performance, cost management efforts, and contracts with public and private customers. These documents also describe non-GAAP measures such as adjusted EBITDA that the company uses internally to analyze operating performance and liquidity.

FAQs about Syra Health Corp.